FDA inspection
University of Utah Cell Therapy and Regenerative Medicine: FDA inspection ending Sep 11, 2026
FDA inspection 1336336 · No Action Indicated (NAI) · Salt Lake City, UT
Key facts
| Inspection ID | 1336336 |
|---|---|
| Firm | University of Utah Cell Therapy and Regenerative Medicine |
| FEI number | 3004471729 |
| City | Salt Lake City |
| State | UT |
| ZIP | 84108 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Sep 11, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data